Ποια είναι η τιμή για Bactiguard Holding AB (publ) (BACTI-B)

Η τιμή για Bactiguard Holding AB (publ) (BACTI-B) είναι $1.66

Ποια είναι η κεφαλαιοποίηση αγοράς για Bactiguard Holding AB (publ) (BACTI-B)

Η κεφαλαιοποίηση αγοράς για Bactiguard Holding AB (publ) (BACTI-B) είναι $58.32M

Bactiguard Holding AB (publ) (BACTI-B) Τιμή και Κεφαλαιοποίηση Αγοράς

Bactiguard Holding AB (publ), a Swedish-based global medical technology company, specializes in developing and supplying innovative solutions designed to prevent infections. Its primary objective is to mitigate healthcare-associated infections (HAIs) and reduce the global dependency on antibiotics. The core of Bactiguard's product line, known as Bactiguard Infection Protection (BIP), encompasses a range of coated medical devices. This includes various urinary catheters, such as the BIP Foley Catheter and the temperature-sensing BIP Foley TempSensor, all engineered to inhibit microbial adhesion and prevent urinary tract infections. Similarly, the BIP Central Venous Catheter and BIP Endotracheal Tube (with the BIP Endotracheal Tube Evac variant offering subglottic secretion drainage) work to reduce the risk of bloodstream and respiratory tract infections by minimizing biofilm formation. Beyond its BIP portfolio, the company offers a diverse array of other products, including Hydrocyn aqua advanced wound care for cleaning and debriding acute, chronic, and infected wounds, as well as general Bactiguard Wound Care items. It also provides a comprehensive selection of surgical sutures (natural absorbable, synthetic absorbable, non-absorbable, and specialty types), VigiMesh for hernia repair, and Hydrocyn aqua advanced disinfectant for sanitizing skin and surfaces. Additionally, Bactiguard supplies specialized orthopedic trauma implants featuring infection prevention technology under the ZNN Bactiguard brand, and the Aniocyn line of wound and skin care products for various pets. Bactiguard Holding AB (publ) was established in 2005 and maintains its headquarters in Tullinge, Sweden.

Η τιμή για BACTI-B	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$148,565 $58.32M	NVDA	$5.206T	+8,926,848.03%
$130,457 $58.32M	AAPL	$4.572T	+7,838,786.19%
$118,336 $58.32M	GOOG	$4.147T	+7,110,448.87%
$102,391 $58.32M	MSFT	$3.588T	+6,152,334.73%
$79,642.22 $58.32M	AMZN	$2.791T	+4,785,419.21%

Η τιμή για BACTI-B

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$148,565 $58.32M